BK polyomavirus: A newly recognized threat to transplanted kidneys

Cleveland Clinic Journal of Medicine

Volumn 70, Issue 12, 2003, Pages 1056-1068

  Braun, William E ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CIDOFOVIR; CREATININE; IMMUNOGLOBULIN; LEFLUNOMIDE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PREDNISONE; RIMANTADINE; TACROLIMUS; THYMOCYTE ANTIBODY;

BK VIRUS; CREATININE BLOOD LEVEL; HEALTH HAZARD; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; KIDNEY ALLOGRAFT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MEDICAL ASSESSMENT; NEPHROTOXICITY; NONHUMAN; PATIENT REFERRAL; RECIPIENT; REVIEW; RISK FACTOR; SCREENING TEST; VIRUS DETECTION; VIRUS INFECTION; VIRUS REACTIVATION;

EID: 0347600492     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.70.12.1056     Document Type: Review

References (36)

1. Mylonakis E, Goes N, Rubin RH, et al. BK virus in solid organ transplant recipients: an emerging syndrome. Transplantation 2001; 72:1587-1592.
2. Gardner SD, Field AM, Coleman DV, et al. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1971; 1:1253-1257.
3. Hogan TF, Borden EC, McBain JA et al. Human polyornavirus infections with JC virus and BK virus in renal transplant patients. Ann Intern Med 1980; 92:373-378.
4. Purighalla R, Shapiro R, McCauley J, et al. BK virus infection in a kidney allograft diagnosed by needle biopsy. Am J Kidney Dis 1995; 26:671-673.
5. Cole CN, Conzen SD. Polyomaviridae: The viruses and their replication. In: Knipe DM, Howley PM, editors. Field's Virology, Vol II. Philadelphia: Lippincott, Williams & Wilkins, 2001: 21-41.
6. Li RM, Mannon RB, Kleiner D, et al. BK virus and SV40 co-infection in polyomavirus nephropathy. Transplantation 2002; 74:1497-1504.
7. Vilchez RA, Butel JS, Kusne S. Polyomaviruses in solid-organ transplant recipients. Transplantation 2002; 74:579-580.
8. Major EO. Human polyomavirus. in: Knipe DM, Howley PM, editors. Fields Virology. Philadelphia: Lippincott Williams & Wilkins, 2001: 2175-2196.
9. Fishman JA. BK virus nephropathy - Polyomavirus adding insult to injury. N Engl J Med 2002; 347:527-530.
10. Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002; 347:488-496.
11. Binet I. Nickeleit V, Hirsch HH, et al. Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss. Transplantation 1999; 67:918-922.
12. Nickeleit V, Klimkait T, Binet IF, et al. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med 2000; 342:1309-1315.
13. Ramos E, Drachenberg CB, Papadimitriou JC, et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 2002; 13:2145-2151.
14. Randhawa PS, Finkelstein S, Scantlebury V, et al. Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation 1999; 67:103-109.
15. Nickeleit V, Hirsch HH, Zeiler M, et al. BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game. Nephrol Dial Transplant 2000; 15:324-332.
16. Nickeleit V, Mihatsch MJ. The pathologist's approach to therapeutic decision making in renal transplantation [abstract]. Transplantation 2002; 74:181.
17. Poduval RD, Meehan SM, Woodle ES, et al. Successful retransplantation after renal allograft loss to polyoma virus interstitial nephritis. Transplantation 2002; 73:1166-1169.
18. Howell DN, Smith SR, Butterly DW, et al. Diagnosis and management of BK polyoMavirus interstitial nephritis in renal transplant recipients. Transplantation 1999; 68:1279-1288.
19. Nickeleit V, Hirsch HH, Binet IF, et al. Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease. J Am Soc Nephrol 1999; 10:1080-1089.
20. Leung AY, Suen CK, Lie AK, et al. Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation. Blood 2001; 98:1971-1978.
21. Al Jedai AH, Honaker MR, Trofe J, et al. Renal allograft loss as the result of polyomavirus interstitial nephritis after simultaneous kidney-pancreas transplantation: results with kidney retransplantation. Transplantation 2003; 75:490-494.
22. Petrogiannis-Haliotis T, Sakoulas G, Kirby J, et al. BK-related polyomavirus vasculopathy in a renal-transplant recipient. N Engl J Med 2001; 345:1250-1255.
23. Haririan A, Ramos ER, Drachenberg CB, et al. Polyomavirus nephropathy in native kidneys of a solitary pancreas transplant recipient. Transplantation 2002; 73:1350-1353.
24. Geetha D, Tong BC, Racusen L, et al. Bladder carcinoma in a transplant recipient: evidence to implicate the BK human polyomavirus as a causal transforming agent. Transplantation 2002; 73:1933-1936.
25. Randhawa PS, Vats A, Zygmunt D, et al. Quantitation of viral DNA in renal allograft tissue from patients with BK virus nephropathy. Transplantation 2002; 74:485-488.
26. Limaye AP, Jerome KR, Kuhr CS, et al. Quantitation of BK virus load in serum for the diagnosis of BK virus-associated nephropathy in renal transplant recipients. J Infect Dis 2001; 183:1669-1672.
27. Ding R, Medeiros; M, Dadhania D, et al. Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK virus VP1 in urine. Transplantation 2002; 74:987-994.
28. Baksh FK, Finkelstein SD, Swalsky PA, et al. Molecular genotyping of BK and JC viruses in human polyomavirus-associated interstitial nephritis after renal transplantation. Am J Kidney Dis 2001; 38:354-365.
29. Ratnamohan VM, Chapman J, House H, et al. Cytomegalovirus and human herpes virus 6 both cause viral disease after renal transplantation. Transplantation 1998; 66:877-882.
30. Tong CY, Bakran A, Williams H, et al. Association of human herpesvirus 7 with cytomegalovirus disease in renal transplant recipients. Transplantation 2000; 70:213-216.
31. Randhawa PS, Demetris AJ. Nephropathy due to polyomavirus type BK. N Engl J Med 2000; 342:1361-1363.
32. Fishman JA. BK nephropathy: What is the role of antiviral therapy? Am J Transplant 2003; 3:99-100.
33. Waldman WJ, Knight DA, Lurain NS, et al. Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide. Transplantation 1999; 68:814-825.
34. Poduval RD, Kadambi PV, Javaid B, et al. Leflunomide - A potential new therapeutic agent for BK nephropathy [abstract]. Am J Transplant 2003; 3(suppl 5):189.
35. Kadambi PV, Josephson MA, Williams J, et al. Treatment of refractory BK virus-associated nephropathy with cidofovir. Am J Transplant 2003; 3:186-191.
36. Leventhal B, Soave R, Mouradian J, et al. Renal dysfunction and hyperglycemia in a renal transplant recipient. Transplant Infect Dis 1999; 1:288-294.